GlaxoSmithKline Plc has invested $5.5 million in Response Genetics Inc through a private share placement giving it 15.2% of the expanded share capital of the US diagnostics company. GSK in-licenses genetic testing services from the company. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
